Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of neuromuscular blockade reversal drugs on intracranial pressure after craniotomy
2009-011696-68Phase 4Terminated
- Sponsor
- University of Nottingham
- Start
- Sep 2009
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of Sugammadex, neostigmine and glycopyrronium in None (2 arms), sponsored by University of Nottingham. Primary endpoint: Change in intracranial pressure following investigational medicinal product administration. Started Sep 2009; status: terminated.
02
Drugs
Sugammadexneostigmineglycopyrronium
Beyond the preview
Go deeper on 2009-011696-68.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011696-68.